Please use this identifier to cite or link to this item:
|Title:||NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy|
|Authors:||Shen, H.-M. |
|Source:||Shen, H.-M., Tergaonkar, V. (2009-04). NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy. Apoptosis 14 (4) : 348-363. ScholarBank@NUS Repository. https://doi.org/10.1007/s10495-009-0315-0|
|Abstract:||It has become increasingly clear that deregulation of the NFκB signaling cascade is a common underlying feature of many human ailments including cancers. The past two decades of intensive research on NFκB has identified the basic mechanisms that govern the functioning of this pathway but uncovering the details of why this pathway works differently in different cellular contexts or how it interacts with other signaling pathways remains a challenge. A thorough understanding of these processes is needed to design better and more efficient therapeutic approaches to treat complex diseases like cancer. In this review, we summarize the literature documenting the involvement of NFκB in cancer, and then focus on the approaches that are being undertaken to develop NFκB inhibitors towards treatment of human cancers. © 2009 Springer Science+Business Media, LLC.|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Feb 22, 2018
WEB OF SCIENCETM
checked on Jan 22, 2018
checked on Feb 25, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.